Effect of obesity and obesity trajectories on the risk of cardiovascular diseases in adult male with incident NAFLD in Northern China

doi:10.16352/j.issn.1001-6325.2022.05.021

Abstract

Abstract: Objective To investigate the baseline and effect of obesity and obesity trajectories on cardiovascular diseases(CVDs) in adult male with incident non-alcoholic fatty liver disease(NAFLD). Methods Adult men with newly diagnosed NAFLD and without CVDs in the Kailuan cohort study from 2006—2013 were enrolled. The subjects were divided into the nonobese group and obese group according to the definition of body mass index(BMI) or waist circumference (WC), then further divided by the obesity trajectories at the first follow-up (1-4 years). Kaplan-Meier method was used to estimate the incidence rate of CVDs for each subgroup. In addition, the Fine and Gray competing risk Cox regression model was used to compare CVDs risk in NAFLD with different baseline or trajectories in obesity measures after 1-4 years of NAFLD diagnosis. Results A total of 8 591 incident NAFLD patients were included. During a median follow-up of 9.41 years, 349 cases were found with CVDs. The 10-year cumulative incidence rates of CVDs were 3.3% and 4.3% in the nonobese and obese groups according to the definition of waist circumference, respectively (log-rank test, P＜0.05). However, the significance disappeared after adjusting the competing risk of death and other covariates. Similar results were observed based on the definition of BMI. Also, further analysis was conducted for the association trajectories in obesity measures and CVDs. The 8-year cumulative incidence rates of CVDs were 2.8%, 3.6%, 4.2%, and 3.3% in the constantly nonobese group, nonobese-obese, obese-nonobese, and constantly obese group, respectively (log-rank test, P＞0.05). Compared to the subjects with constantly nonobese defined by BMI, those who transition from nonobese to obese increased the CVDs risk by 57% (hazard ratio [HR]:1.57; 95% CI:1.03~2.38; P＜0.05). The conclusion remained even after adjusting baseline BMI (HR:1.56; 95% CI:1.02~2.37; P＜0.05). Conclusions Short-term weight gain in men with incident NAFLD led a higher CVDs risk, suggesting the importance of weight control in preventing CVDs once NAFLD occurrence.

Key words: obesity, non-alcoholic fatty liver disease, cardiovascular diseases, cohort study

CLC Number:

R181.3

HU Shi-qi, LAN Yan-qi, WU Shou-ling, WANG Xiao-mo, CHEN Shuo-hua, WANG Guo-dong, WANG Li. Effect of obesity and obesity trajectories on the risk of cardiovascular diseases in adult male with incident NAFLD in Northern China[J]. Basic & Clinical Medicine, 2022, 42(5): 788-794.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.05.021

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I5/788

References

[1] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018,67:328-357.
[2]Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention[J]. Nat Rev Gastro Hepat, 2018,15:11-20.
[3]Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016,64:73-84.
[4]Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?[J]. Diabetologia, 2008,51:1947-1953.
[5]Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J]. New Engl J Med, 2010,363:1341-1350.
[6]Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review[J]. Gastroenterology, 2021,160:912-918.
[7]Wang F, Wu S, Song Y, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese[J]. Nutr Metab Cardiovas, 2009,19:542-547.
[8]World Health Organization. Waist circumference and waist-hip ratio report of a WHO expert consultation[EB/OL]. https://apps.who.int/iris/handle/10665/44583, (2008-12-31)
[9]WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004,363:157-163.
[10] Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk[J]. J Am Stat Assoc, 1999,94:496-509.
[11] Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018,24:908-922.
[12] Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a syste-matic review[J]. J Hepatol, 2008,49:600-607.
[13] Wang AY, Dhaliwal J, Mouzaki M. Lean non-alcoholic fatty liver disease[J]. Clin Nutr, 2019,38:975-981.
[14] Pang Q. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index[J]. World J Gastroentero, 2015,21:1650-1651.
[15] Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study[J]. J Hepatol, 2009,51:1061-1067.